Paragraph IV Challenges
✉ Email this page to a colleague
Tradename | Dosage | Generic Name | NDA | ANDAs Submitted | 180 Day Exclusivity Status | Submissiondate |
---|---|---|---|---|---|---|
BELSOMRA | Tablets | suvorexant | 204569 | 1 | 2024-03-04 | |
NURTEC ODT | Orally Disintegrating Tablets | rimegepant sulfate | 212728 | 7 | 2024-02-27 | |
AVYCAZ | For Injection | avibactam sodium; ceftazidime | 206494 | 2 | 2024-02-26 | |
INJECTAFER | Injection | ferric carboxymaltose | 203565 | 1 | 2024-02-22 | |
NEXLETOL | Tablets | bempedoic acid | 211616 | 9 | 2024-02-21 | |
NEXLIZET | Tablets | bempedoic acid; ezetimibe | 211617 | 3 | 2024-02-21 | |
VALTOCO | Nasal Spray | diazepam | 211635 | 1 | 2024-02-14 | |
>Tradename | >Dosage | >Generic Name | >NDA | >ANDAs Submitted | >180 Day Exclusivity Status | >Submissiondate |